Boston Therapeutics, Inc. Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Description of Securities of Nanomix Corporation (Filed With SEC on April 7, 2023)
- Offer Letter for Chris Hetterly, dated November 15, 2022 (Filed With SEC on January 25, 2023)
- Offer Letter, dated July 21, 2022 (Filed With SEC on July 29, 2022)
- Offer Letter, dated February 28, 2022 (Filed With SEC on May 10, 2022)
- Description of Securities of Nanomix Corporation (Filed With SEC on April 12, 2022)
- Unwind Agreement between Boston Therapeutics, Inc., Cure DM, Inc. and Cure DM Group Holdings, LLC signed August 6, 2019 (Filed With SEC on August 19, 2019)
- Certificate of Designation dated August 14, 2017 (Filed With SEC on August 22, 2017)
- Letter Agreement dated March 27, 2017 entered between Boston Therapeutics, Inc. and Carl W. Rausch (Filed With SEC on March 28, 2017)
- Letter Agreement between the Company and CJY Holdings Limited dated August 12, 2016 (Filed With SEC on August 15, 2016)
- Form of 6% Senior Convertible Debuenture (Filed With SEC on August 15, 2016)
- Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated June 28, 2016 (Filed With SEC on July 6, 2016)
- Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated May 6, 2016 (Filed With SEC on May 12, 2016)
- Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated March 11, 2016 (Filed With SEC on March 22, 2016)
- Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated March 1, 2016 (Filed With SEC on March 2, 2016)
- Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated November 30, 2015 (Filed With SEC on December 10, 2015)
- Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited (Filed With SEC on October 30, 2015)
- Letter Agreement by and between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC (Filed With SEC on October 2, 2015)
- Boston Therapeutics, Inc. OTCQB:BTHE1750 Elm Street Suite 103Manchester, NH03104Tel: (603) 935-9799Fax: (603) 685-4784www.bostonti.com (Filed With SEC on November 13, 2012)
